NextCure Inc (NXTC)
NASDAQ
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Return on Assets (%) | -158.925 | -27.289 | -13.393 | -11.045 | -25.277 | -35.041 | -40.181 |
Return on Equity (%) | 126.733 | 63.902 | -24.577 | -11.899 | -26.328 | -37.281 | -44.492 |
Return on Invested Capital (%) | -194.096 | -35.431 | -17.207 | -13.441 | -26.934 | -38.234 | -48.87 |
Operating Margin (%) | N/A | N/A | -531.542 | -163.567 | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | -531.542 | -163.567 | N/A | N/A | N/A |
Book Value Per Share | 11.386 | 83.839 | 11.691 | 10.654 | 8.431 | 6.032 | 4.101 |
Earnings Per Share | -11.299 | -16.581 | -1.227 | -1.328 | -2.507 | -2.691 | -2.248 |
Cash Per Share | 6.156 | 98.308 | 1.24 | 1.189 | 0.446 | 0.959 | 0.469 |
Working Capital Per Share | 4.599 | 91.263 | 11.817 | 10.071 | 7.991 | 5.575 | 3.793 |
Operating Profit Per Share | N/A | N/A | 0.231 | 0.812 | N/A | N/A | N/A |
EBIT Per Share | -11.299 | -16.581 | -1.227 | -1.328 | -2.507 | -2.691 | -2.248 |
EBITDA Per Share | -11.299 | -16.581 | -1.227 | -1.328 | -2.507 | -2.691 | -2.248 |
Free Cash Flow Per Share | -5.405 | -15.573 | -1.202 | -1.193 | -2.577 | -2.763 | -2.351 |
Year End December 30 2023 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|
Current Ratio | 3.015 | 13.186 | 22.603 | 27.891 | 34.476 | 17.967 | 16.377 |
Quick Ratio | 2.973 | 13.171 | 22.358 | 27.618 | 33.237 | 17.521 | 15.734 |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Shares Outstanding | 1.37M | 1.38M | 27.5M | 27.57M | 27.68M | 27.78M | N/A |
Year End December 30 2023 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | ||
Shares Outstanding | 27.75M | 27.75M | 27.78M | N/A | N/A | N/A | N/A | N/A |
Return on Assets (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Equity (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Return on Invested Capital (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Net Profit Margin (%) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Sales Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Book Value Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Earnings Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Cash Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Working Capital Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Operating Profit Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBIT Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
EBITDA Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Free Cash Flow Per Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Current Ratio | N/A | N/A | N/A | 23.766 | N/A | N/A | N/A | 10.701 |
Quick Ratio | N/A | N/A | N/A | 23.219 | N/A | N/A | N/A | 10.018 |
Inventory Turnover (Days) | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
Market Cap | 45.04M |
Price to Earnings Ratio | -0.72 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 3.44 |
Price to Book Ratio | 0.39 |
Dividend Yield | - |
Shares Outstanding | 27.97M |
Average Volume (1 week) | 23.37k |
Average Volume (1 Month) | 41.4k |
52 Week Change | -5.29% |
52 Week High | 2.57 |
52 Week Low | 0.98 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.